Effect of siRNA-induced Atg7 gene silencing on the sensitivity of ovarian cancer SKOV3 cells to cisplatin. 2020

Xuan Zhang, and Liang-Liang Wang, and Beibei Wang, and Hong-Li Liu, and Jing Zhang, and Yan-Hua Li, and Li-Hua Wang
Department of Oncological Gynecology, First Affiliated Hospital of Bengbu Medical College Bengbu 233000, China.

Ovarian cancer is one of the most common types of gynecological malignant tumors. A proclivity for, or the development of chemoresistance severely affects treatment efficacy for ovarian cancer. Herein we found that as concentrations of cisplatin (DDP) used in SKOV3 cells increased, expression of intracellular reactive oxygen species (ROS) increased as did amounts of proteins of Beclin-1 and Autophagy-Related Gene 7 (Atg7) whereas in contrast, expression of P62 protein decreased gradually. Expression of Atg7 protein in SKOV3 cells in the siRNA-Atg7 transfection treatment group was significantly reduced compared to the negative control group. Post-application of DDP treatments, the apoptotic ratio of SKOV3 cells in the siRNA-Atg7 transfection group increased, and the cell survival rate decreased to a level significantly lower than in the negative control group. Cellular morphological analyses revealed remarkably decreased measures of cell density, as well as shrunk, deformed, and rounded cells with unclear boundaries, and revealed a decreased measures of mitochondrial membrane potential. Taken together, autophagy may be involved in the dynamics and mechanistics underlying DDP resistance in ovarian cancer SKOV3 cells. Thus, inhibition of autophagy through down-regulation expression of Atg7 may have beneficially enhanced the sensitivity of SKOV3 cells to DDP-based chemotherapy which could help improve treatment outcomes for patients afflicted by ovarian cancer.

UI MeSH Term Description Entries

Related Publications

Xuan Zhang, and Liang-Liang Wang, and Beibei Wang, and Hong-Li Liu, and Jing Zhang, and Yan-Hua Li, and Li-Hua Wang
May 2011, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Xuan Zhang, and Liang-Liang Wang, and Beibei Wang, and Hong-Li Liu, and Jing Zhang, and Yan-Hua Li, and Li-Hua Wang
August 2005, Ai zheng = Aizheng = Chinese journal of cancer,
Xuan Zhang, and Liang-Liang Wang, and Beibei Wang, and Hong-Li Liu, and Jing Zhang, and Yan-Hua Li, and Li-Hua Wang
January 2015, Molecular medicine reports,
Xuan Zhang, and Liang-Liang Wang, and Beibei Wang, and Hong-Li Liu, and Jing Zhang, and Yan-Hua Li, and Li-Hua Wang
October 2021, Molecular medicine reports,
Xuan Zhang, and Liang-Liang Wang, and Beibei Wang, and Hong-Li Liu, and Jing Zhang, and Yan-Hua Li, and Li-Hua Wang
May 2019, Journal of cellular biochemistry,
Xuan Zhang, and Liang-Liang Wang, and Beibei Wang, and Hong-Li Liu, and Jing Zhang, and Yan-Hua Li, and Li-Hua Wang
February 2018, Archives of gynecology and obstetrics,
Xuan Zhang, and Liang-Liang Wang, and Beibei Wang, and Hong-Li Liu, and Jing Zhang, and Yan-Hua Li, and Li-Hua Wang
February 2022, Zhonghua zhong liu za zhi [Chinese journal of oncology],
Xuan Zhang, and Liang-Liang Wang, and Beibei Wang, and Hong-Li Liu, and Jing Zhang, and Yan-Hua Li, and Li-Hua Wang
December 2016, Experimental and therapeutic medicine,
Xuan Zhang, and Liang-Liang Wang, and Beibei Wang, and Hong-Li Liu, and Jing Zhang, and Yan-Hua Li, and Li-Hua Wang
August 2022, Medical oncology (Northwood, London, England),
Xuan Zhang, and Liang-Liang Wang, and Beibei Wang, and Hong-Li Liu, and Jing Zhang, and Yan-Hua Li, and Li-Hua Wang
July 2017, Oncology reports,
Copied contents to your clipboard!